SPStephen R. Planck

Stephen R. Planck

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Stephen R. Planck has a total of 169 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Non-specific orbital inflammation: Current understanding and unmet needs

    by Min Joung Lee, Stephen R. Planck, Dongseok Choi, Christina A. Harrington, David J. Wilson, Roger A. Dailey, John D. Ng, Eric A. Steele, Bronwyn E. Hamilton, Sang In Khwarg, et al.


  • Open Access

    Identifying RNA Biomarkers and Molecular Pathways Involved in Multiple Subtypes of Uveitis

    by James T. Rosenbaum, Christina A. Harrington, Robert P. Searles, Suzanne S. Fei, Amr Zaki, Sruthi Arepalli, Michael A. Paley, Lynn M. Hassman, Albert T. Vitale, Christopher D. Conrady, et al.


  • Revising the Diagnosis of Idiopathic Uveitis by Peripheral Blood Transcriptomics

    by James T. Rosenbaum, Christina A. Harrington, Robert P. Searles, Suzanne S. Fei, Amr Zaki, Sruthi Arepalli, Michael A. Paley, Lynn M. Hassman, Albert T. Vitale, Christopher D. Conrady, et al.


  • Gene Expression Pathways across Multiple Tissues in Antineutrophil Cytoplasmic Antibody-associated Vasculitis Reveal Core Pathways of Disease Pathology

    by Marcia A. Friedman, Dongseok Choi, Stephen R. Planck, James T. Rosenbaum, Cailin H. Sibley

    Objective.: To identify commonalities in gene expression data across all antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) tissues thus far characterized.Methods.: Gene expression data were collected from the 3 AAV tissues thus far characterized (orbit, peripheral leukocytes, and sinus brushings). These data were analyzed to identify commonly expressed genes and disease pathways. The pathways data were adjusted for multiple comparisons using a combined local false discovery rate, which estimates the probability of a false discovery of a given pathway in all 3 tissues analyzed.Results.: Only 4 genes were upregulated in all 3 tissues —IL1RN,TLR2, SLC11A1, andMMP9. After multiple comparison adjustments, the network pathway analysis revealed 28 pathways associated with all 3 tissues. The most strongly associated pathway for all 3 tissues was the neutrophil degranulation pathway [multidimensional local false discovery (md-locfdr) = 1.05 × 10−12], followed by the osteoclast differentiation (md-locfdr = 3.8 × 10−05), cell surface interactions at the vascular wall (md-locfdr = 4.2 × 10−04), signaling by interleukins (md-locfdr = 6.1 × 10−04), and phagosome (md-locfdr = 0.003) pathways. There were no downregulated genes or pathways common to all 3 tissues.Conclusion.: This analysis identified individual genes and pathways of disease common to all AAV tissues thus far characterized. The use of a network pathway analysis allowed us to identify pathologic mechanisms that were not readily apparent in the commonly expressed genes alone. Many of these pathways are consistent with current theories about infectious drivers and the crossroads of innate and adaptive immune mechanisms. In addition, this analysis highlights novel pathways, such as vessel wall interactions and platelet activation, which require further investigation.


  • Open Access

    Gene Expression Profiling and Heterogeneity of Nonspecific Orbital Inflammation Affecting the Lacrimal Gland

    by James T. Rosenbaum, Dongseok Choi, Christina A. Harrington, David J. Wilson, Hans E. Grossniklaus, Cailin H. Sibley, Sherveen S. Salek, John D. Ng, Roger A. Dailey, Eric A. Steele, et al.

    Dacryoadenitis has a broad differential diagnosis that includes sarcoidosis, nonspecific orbital inflammation (NSOI), Sjögren syndrome, and, less commonly, entities like granulomatosis with polyangiitis (GPA), thyroid eye disease (TED), or IgG4-related disease.1-5 Other considerations in the differential diagnosis are infections, tumors (including lymphoma), and lymphoid hyperplasia. Among these diagnoses, nonspecific inflammation is the most common biopsy diagnosis.2


  • Molecular diagnosis: Implications for ophthalmology

    by James T. Rosenbaum, Cailin H. Sibley, Dongseok Choi, Christina A. Harrington, Stephen R. Planck


  • Orbital pseudotumor can be a localized form of granulomatosis with polyangiitis as revealed by gene expression profiling

    by James T. Rosenbaum, Dongseok Choi, David J. Wilson, Hans E. Grossniklaus, Christina A. Harrington, Cailin H. Sibley, Roger A. Dailey, John D. Ng, Eric A. Steele, Craig N. Czyz, et al.


  • Open Access

    Insights in to the pathogenesis of axial spondyloarthropathy based on gene expression profiles

    by Srilakshmi M Sharma, Dongseok Choi, Stephen R Planck, Christina A Harrington, Carrie R Austin, Jinnell A Lewis, Tessa N Diebel, Tammy M Martin, Justine R Smith, James T Rosenbaum

    Introduction: Axial spondyloarthropathy (SpA) is a group of inflammatory diseases, with ankylosing spondylitis as the prototype. SpA affects the axial skeleton, entheses, joints and, at times, the eyes. This study tested the hypothesis that SpA is characterized by a distinct pattern of gene expression in peripheral blood of affected individuals compared with healthy controls. Methods: High-density, human GeneChip® probe arrays were used to profile mRNA of peripheral blood cells from 18 subjects with SpA and 25 normal individuals. Samples were processed as two separate sets at different times (11 SpA + 12 control subjects in primary set (Set 1); 7 SpA+ 13 control subjects in the validation set (Set 2)). Blood samples were taken at a time when patients were not receiving systemic immunomodulatory therapy. Differential expression was defined as a 1.5-fold change with a q value < 5%. Gene ontology and pathway information were also studied. Results: Signals from 134 probe sets (representing 95 known and 12 unknown gene transcripts) were consistently different from controls in both Sets 1 and 2. Included among these were transcripts for a group of 20 genes, such as interleukin-1 (IL-1) receptors 1 and 2, Nod-like receptor family, pyrin domain containing 2 (NLRP2), secretory leukocyte peptidase inhibitor (SLPI), secreted protein acidic and rich in cysteine (SPARC), and triggering receptor expressed on myeloid cells 1 (TREM-1) that are clearly related to the immune or inflammatory response and a group of 4 transcripts that have a strong role in bone remodeling. Conclusions: Our observations are the first to implicate SPARC, SLPI, and NLRP2, a component of the innate immune system, in the pathogenesis of SpA. Our results also indicate a possible role for IL-1 and its receptors in SpA. In accord with the bone pathology component of SpA, we also found that expression levels of transcripts reflecting bone remodeling factors are also distinguishable in peripheral blood from patients with SpA versus controls. These results confirm some previously identified biomarkers implicated in the pathogenesis of SpA and also point to novel mediators in this disease.


  • Open Access

    Gene expression profiling of whole blood: Comparison of target preparation methods for accurate and reproducible microarray analysis

    by Kristina Vartanian, Rachel Slottke, Timothy Johnstone, Amanda Casale, Stephen R Planck, Dongseok Choi, Justine R Smith, James T Rosenbaum, Christina A Harrington

    Background: Peripheral blood is an accessible and informative source of transcriptomal information for many human disease and pharmacogenomic studies. While there can be significant advantages to analyzing RNA isolated from whole blood, particularly in clinical studies, the preparation of samples for microarray analysis is complicated by the need to minimize artifacts associated with highly abundant globin RNA transcripts. The impact of globin RNA transcripts on expression profiling data can potentially be reduced by using RNA preparation and labeling methods that remove or block globin RNA during the microarray assay. We compared four different methods for preparing microarray hybridization targets from human whole blood collected in PAXGene tubes. Three of the methods utilized the Affymetrix one-cycle cDNA synthesis/in vitro transcription protocol but varied treatment of input RNA as follows: i. no treatment; ii. treatment with GLOBINclear; or iii. treatment with globin PNA oligos. In the fourth method cDNA targets were prepared with the Ovation amplification and labeling system. Results: We find that microarray targets generated with labeling methods that reduce globin mRNA levels or minimize the impact of globin transcripts during hybridization detect more transcripts in the microarray assay compared with the standard Affymetrix method. Comparison of microarray results with quantitative PCR analysis of a panel of genes from the NF-kappa B pathway shows good correlation of transcript measurements produced with all four target preparation methods, although method-specific differences in overall correlation were observed. The impact of freezing blood collected in PAXGene tubes on data reproducibility was also examined. Expression profiles show little or no difference when RNA is extracted from either fresh or frozen blood samples. Conclusion: RNA preparation and labeling methods designed to reduce the impact of globin mRNA transcripts can significantly improve the sensitivity of the DNA microarray expression profiling assay for whole blood samples. While blockage of globin transcripts during first strand cDNA synthesis with globin PNAs resulted in the best overall performance in this study, we conclude that selection of a protocol for expression profiling studies in blood should depend on several factors, including implementation requirements of the method and study design. RNA isolated from either freshly collected or frozen blood samples stored in PAXGene tubes can be used without altering gene expression profiles.


  • T cell–antigen-presenting cell interactions visualized in vivo in a model of antigen-specific inflammation

    by James T. Rosenbaum, Mischa B. Ronick, Xubo Song, Dongseok Choi, Stephen R. Planck